Objective: To develop a brief symptom survey specific for persons with
glaucoma, the Glaucoma Symptom Scale (GSS). Design: Cross-sectional s
tudy of symptoms, functional impairment, and vision-targeted health-re
lated quality of life among persons with glaucoma. Patients: A sample
of 147 persons with glaucoma among a broad range of treatment categori
es from 4 tertiary care glaucoma centers and 44 persons without eye di
sease enrolled from the same 4 centers. Main Outcome Measures: Partici
pants completed a modified version of the Ocular Hypertension Treatmen
t Study 10-item symptom checklist. Participants also completed 2 visio
n-specific measures, the National Eye Institute Visual Function Questi
onnaire and the VF-14. Participants underwent a clinical evaluation, i
ncluding ocular and medical history, dilated ophthalmic examination, a
nd Humphrey 24-2 automated visual field testing. Results: The GSS has
2 underlying domains that demonstrate sufficient internal consistency
reliability for between-group comparisons. The GSS discriminates well
between persons with and without glaucoma. Additionally, tests of asso
ciation with clinical markers of glaucoma severity support the clinica
l validity of the measure and tests of association with established vi
sion-targeted measures provide evidence of construct validity. Conclus
ion: The simplicity, brevity, and psychometric properties of the GSS s
upport its use in clinical practice and research to quantify symptoms
in patients with glaucoma and to assist in investigations concerning t
he effect of glaucoma and treatments.